Minimally Invasive Pancreaticoduodenectomy on the Rise
Minimally invasive pancreaticoduodenectomy (MIPD) approaches are gaining traction, with robotic techniques significantly reducing hospital stays compared to traditional open surgery.
Newsletter
HPB & Spleen
Every new paper in this field, in your inbox.
New Consensus Framework for HCC Treatment Allocation
A new consensus-based framework called beacon-hcc provides a refined approach to treatment decisions for hepatocellular carcinoma (HCC), aligning therapy with tumor biology and emerging modalities.
Radical Antegrade Modular Pancreatosplenectomy Improves Outcomes
In T3 body and tail pancreatic ductal adenocarcinoma (PDAC), radical antegrade modular pancreatosplenectomy (RAMPS) significantly enhances recurrence-free survival (RFS) and overall survival (OS) compared to standard resection.
New Guidelines for Pancreatic Cyst and HCC Surveillance in Seniors
This update offers critical insights on discontinuing surveillance for pancreatic cystic lesions (PCLs) and hepatocellular carcinoma (HCC) in older adults, emphasizing a tailored approach based on individual risk.
Impact of Splenectomy on Left-Sided Pancreatectomy Outcomes
Left-sided pancreatectomy with splenectomy shows no advantage in reducing in-hospital mortality or major complications compared to nonsplenectomy procedures in traumatic pancreatic injuries.
Endobiliary RFA Benefits Survival in Unresectable Cholangiocarcinoma
Endobiliary radiofrequency ablation (RFA) significantly improves survival in patients with unresectable perihilar cholangiocarcinoma, particularly when performed shortly after biliary drainage.
Enucleation Outperforms Pancreatoduodenectomy for Small Tumors
Pancreatic enucleation, despite higher rates of clinically relevant postoperative pancreatic fistula (CR-POPF), shows significant benefits over pancreatoduodenectomy for benign or low-grade tumors in terms of major complications, hospitalization duration, and long-term quality of life.
Predicting Survival in Resected Pancreatic Cancer Using Gene Mutations
This study developed a survival prediction model integrating somatic driver gene mutations in patients with resected pancreatic ductal adenocarcinoma (PDAC), revealing that a higher number of mutations correlates with increased mortality risk.
Living Donor Transplant Shows Promise for Unresectable ICCA
Living donor liver transplant (LDLT) can be a viable option for select patients with unresectable intrahepatic cholangiocarcinoma (ICCA) amidst deceased donor shortages.
New Classification for Postpancreatectomy Hemorrhage
A new consequence-based classification for postpancreatectomy hemorrhage (PPH) offers better predictive value for surgical outcomes than the outdated 2007 criteria.